Hormone profiles, body mass index and aging male symptoms: Results of the Androx Vienna Municipality study

Aging Male

Volumn 7, Issue 3, 2004, Pages 188-196

  Kratzik, C W ^a,e   Reiter, W J ^b   Riedl, A M ^a   Lunglmayrt, G ^c   Brandstatter N ^a   Rucklinger E ^d   Metka, M ^a   Huber, J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Komeuburg Hospital   (Austria)

^c Weinviertel Klinikum   (Austria)

^d KEG   (Austria)

^e Urologische Universitatsklinik   (Austria)

Author keywords

AMS score; Body mass index; Hormones

Indexed keywords

ANDROGEN; HORMONE; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; AGING; ANDROPAUSE; ARTICLE; BODY MASS; HEALTH ECONOMICS; HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; AGING; ANDROGENS; ANDROPAUSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; HEALTH STATUS; HORMONES; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; TESTOSTERONE;

EID: 4744347230     PISSN: 13685538     EISSN: None     Source Type: Journal    
DOI: 10.1080/13685530412331284650     Document Type: Article

References (26)

1. Gray A, Feldman HA, McKinlay JB, et al. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73:1016-25
2. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589-98
3. Vermeulen A, Kaufman JM. Ageing of the hypothalamo-pituitary-testicular axis in men. Horm Res 1995;43:25-8
4. Wespes E, Schulmann CC. Male andropause: myth, reality and treatment. Int J Impot Res 2002;14(Suppl 1):93-8
5. Morales A, Heaton JP, Carson CC 3rd. Andropause: a misnomer for a true clinical entity. J Urol 2000;163:705-12
6. Basaria S, Dobs AS. Hypogonadism and androgen replacement therapy in elderly men. Am J Med 2000;110:563-72
7. Howell S, Shalet S. Testosterone deficiency and replacement. Harm Res 2001;56:86-92
8. Behre HM, Kliesch S, Leifke E, et al. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997;82:2386-90
9. Snyder PJ, Peachey H, Berlin JA, et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000;85:2670-7
10. Morley JE. Testosterone replacement in older men and women. J Gend Specif Med 2001;4:49-53
11. Tenover JL. Testosterone replacement therapy in older adult men. Int J Androl 1999;22:300-6
12. Seidman SN, Spatz E, Rizzo C, et al. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatry 2000;2:406-12
13. Morales A. Testosterone replacement: when is there a role? Int J Impot Res 2000;12:112-8
14. Diczfalusy E. An aging humankind revised. Aging Male 1998;1:8-19
15. United Nations Population Division, World Population Prospects: The 2002 Revision Population Database http://www.un.org/News/Press/docs/2003/pop850.doc. htm
16. Heinemann LAJ, Zimmermann T, Vermeulen A, et al. A new 'aging males' symptoms' rating scale. Aging Male 1999;2:105-14
17. Giagulli VA, Kaufman JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab 1994;79:997-1000
18. Ukkola O, Gagnon J, Rankinen T, et al. Age, body mass index, race and other determinants of steroid hormone variability: the HERITAGE Family Study. Eur J Endocrinol 2001;145:1-9
19. Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-31
20. Allen NE, Appleby PN, Davey GK, et al. Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. Cancer Causes Control 2002;13:353-63
21. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49:1239-49
22. Heinemann LAJ, Saad F, Thiele K, et al. The Aging Males' Symptoms rating scale: cultural and linguistic validation into English. Aging Male 2001;4:14-22
23. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26
24. Bartsch W. Interrelationships between sex hormone-binding globulin and testosterone, 5 alpha-dihydrotestosterone and oestradiol-17 beta in blood of normal men. Maturitas 1980;2:109-18
25. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM International Society for the Study of the Aging Male. Aging Male 2002;5:74-86
26. Tremblay RR. Practical consequences of the validation of a mathematical model in assessment of partial androgen deficiency in the aging male using bioavailable testosterone. Aging Male 2001;4:23-9